Partial deletion of the short arm of chromosome 1 syndrome

Partial deletion of the short arm of chromosome 1 syndrome (also referred to as 1p partial monosomy or partial monosomy 1p) encompasses a group of rare chromosomal disorders caused by the loss of a segment of genetic material from the short arm (p arm) of chromosome 1. Because chromosome 1 is the largest human chromosome, the clinical presentation varies considerably depending on the size and precise location of the deleted segment. Different subtypes exist based on the specific region involved, such as 1p36 deletion syndrome (the most well-characterized), as well as more proximal or interstitial deletions. The syndrome typically affects multiple body systems. Common clinical features may include intellectual disability of variable severity, developmental delay, distinctive craniofacial features (such as a broad or flat nasal bridge, deep-set eyes, and microcephaly), growth retardation, hypotonia (low muscle tone), seizures, and congenital heart defects. Structural brain abnormalities, vision and hearing problems, skeletal anomalies, and feeding difficulties in infancy may also be present. The severity and combination of features depend heavily on which genes are lost within the deleted region. There is currently no cure or targeted therapy for partial deletion of the short arm of chromosome 1. Management is supportive and symptomatic, tailored to the individual's specific clinical manifestations. This may include early intervention programs, speech and physical therapy, antiepileptic medications for seizure control, cardiac monitoring or surgical correction of heart defects, and specialized educational support. Regular multidisciplinary follow-up with genetics, neurology, cardiology, and developmental specialists is recommended to optimize outcomes and quality of life.

Common questions about Partial deletion of the short arm of chromosome 1 syndrome